Winrevair, which Merck has identified as a “growth driver,” significantly improved blood flow through the lungs to the heart ...
The company reported positive results from a trial of the heart drug that the company is counting on for much of its growth.
A low dose of colchicine — a commonly used gout drug — helped reduce the risk of heart attack and stroke in people with ...
A huge study shows two popular diabetes drugs also protect the heart. Both lower the risk of heart attack and stroke in real patients.
News-Medical.Net on MSN
Study compares the kidney, cardiovascular and mortality risks of three different GLP-1 RAs
Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent ...
Researchers found cardiovascular drugs were associated with 24.7 percent of all medication errors, followed by antibiotics at 19.1 percent, electrolytes at 11.3 percent, endocrine drugs at 8.8 percent ...
Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications like ...
By Deena Beasley (Reuters) -Adding Amgen's cholesterol drug Repatha to standard therapy reduced major cardiovascular events ...
The heart benefits of semaglutide, the active ingredient in drugs such as Wegovy and Ozempic, do not depend on how much weight a person loses ...
Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study. Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to ...
Diabetes drugs such as semaglutide already have a reputation for lowering the risk of cardiovascular events in people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results